Global Pharmaceutical Fine Chemicals Procurement Market Intelligence Report 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The "Global
Pharmaceutical Fine Chemicals Category – Procurement Market Intelligence
Report"
report has been added to ResearchAndMarkets.com's
offering.

Procurement research report on the pharmaceutical fine chemicals market
provides procurement professionals with up-to-date information about
market shifts and potential risks, as well as in-depth knowledge of
products and services. This report provides a detailed analysis of the
supply market, procurement challenges, and procurement best practices,
which can help in planning and executing category management activities.
It also focuses on the cost-saving aspects of procurement and on
providing insights that can lead to optimization of category spend.

One of the primary drivers of the pharmaceuticals fine chemicals
industry is the increase in drug product approvals in the US by the FDA
and in the EU by the EMA. Drug approval is a new opportunity for
pharmaceutical fine chemicals manufacturers as pharmaceutical fine
chemicals are used as raw materials in the drug formulation process.
Furthermore, new drug approvals and patent cliff are leading to the bulk
production of several drugs. This, in turn, will be a direct driver for
the pharmaceutical fine chemicals industry.

One of the procurement best practices for buyers is to adopt measures to
enhance visibility over the supply chain. Buyers need to adopt systems
and practices that can improve their visibility over the entire supply
chain by utilizing digital systems such as QMS, CRM, SCM, and ERP. These
digital systems combined with analytical tools can ensure seamless flow
of information and provide traceability and visibility across the supply
chain.

Key Topics Covered:

Part 1: Category At A Glance

Part 2: Scope Of The Report

Part 3: Market Insights

Part 4: Supply Market Insights

Part 5: Pricing Insights

Part 6: Procurement Insights

Part 7: Top Five Suppliers

  • Lonza
  • BASF
  • Evonik
  • DSM
  • Boehringer Ingelheim

For more information about this report visit https://www.researchandmarkets.com/research/kdv43c/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Chemicals,
Pharmaceutical
Intermediates